Bortolotti F, Bertaso A, Gottardo R, Musile G, Tagliaro F. Dextromethorphan/Levomethorphan issues in a case of Opiate overdoe. Drug Test and Ana, 2013; 5:781-784. https://doi.org/10.1002/dta.1577 |
|
CAS. Chemical Abstracts Service. 2018; Available at: http:// www.chemnet.com/cas/supplier.cgi?terms=30356-07-1&l=en&exact=dict &f=plist&mark=&submit.x=0&submit.y=0 [Accessed 12 Jan 2018]. | |
|
Cersósimo M, Micheli F. Antiglutamatergic drugs in the treatment of Parkinson's disease. Handbook of Clinical Neurology. 2007; 84: 127-136. https://doi.org/10.1016/S0072-9752(07)84036-X | |
|
Divi et al. Resolution of 1-(4-Methoxybenzyl)-1,2,3,4,5,6,7,8- octahydroisoquinoline. Patent No. US 8,148,257 B1. 2012. | |
|
Demian et al. Separation of Enantiomers of Octahydroisoquinoline. Patent No. US 006063925 A. 2000. | |
|
EP 9.0. Dextromethorphan hydrobromide. The European Directorate for the Quality of Medicines & HealthCare, 2017; 2233-2234. | |
|
Guangyue Li, Peiyuan Y, Peiqian C, Jie R, Lei W, Jinhui F, Peter C, Qiaqing W, Dunming Z. New recombinant cyclohexylamine oxidase variants for deracemization of secondary amines by orthogonally assaying designed mutants with structurally diverse substrates. Sci. Rep. 2016; ID 24973. | |
|
ICH. Impurities in new drug substances. Q3A(R2). ICH harmonised tripartite guideline. 2006. | |
|
ICH. Validation of analytical procedures: Text and methodology. Q2 (R1). ICH Harmonised Tripartite Guideline. 2005. | |
|
Kikura R., Kawamura M, Miyajima A, Sunouchi M, Goda Y. Chiral analyses of dextromethorphan/levomethorphan and their metabolites in rat and human samples using LC-MS/MS. Anal. Bioanal Chem, 2011; 400:165-74. https://doi.org/10.1007/s00216-011-4707-y | |
|
Krait S, Heuermann M, Scriba G. Development of a capillary electrophoresis method for the determination of the chiral purity of dextromethorphan by a dual selector system using quality by design methodology. J Sep Sci, 2018; 41:1405-1413. https://doi.org/10.1002/jssc.201701166 | |
|
Lurie I, Kimberly A. Rapid Chiral Separation of Dextro- and Levo- Methorphan using Capillary. Electrophoresis with Dynamically Coated Capillaries. Microgram J, 2005. 3:138-141; Available at: http://forendex. safs1966.org/uploads/references/MicrogramJournal/3.3-4.138.141.pdf [Accessed 05 Feb 2018]. | |
|
Magellan Rx Management. Cough and Cold Therapeutic Class Review. 2016; Available at: https://hhs.texas.gov/sites/default/ files/documents/about-hhs/communications-events/meetings-events/ dur/042817-4o.pdf [Accessed 05 Feb 2018]. | |
|
Nuedexta. Dextromethorphan. EMA/CHMP/80029/2013. European Medicines Agency. EMA. 2013. | |
|
PDR. Dextromethorphan hydrobromide-Drug summary. Prescribers Digital Reference. 2018; Available at: http://www.pdr.net/ drug-summary/Maximum-Strength-Mucinex-DM-dextromethorphan-hydrobromide-guaifenesin-2165 [Accessed 21 Jan 2018]. | |
|
Pharmeuropa. Dextromethorphan hydrobromide Monohydrate. Reference: PA/PH/Exp. 11/T (17) 98 ANP. The European Directorate for the Quality of Medicines & HealthCare, 2017; 2233-2234; Available at: http://pharmeuropa.edqm.eu/TextsForComment [Accessed 02 Jan 2018]. | |
|
Rxlist. 2017. Available at: https://www.rxlist.com/nuedexta-drug.htm [Accessed 05 Jan 2018]. | |
|
Sigma-Aldrich. 2018; Available at: https://www.sigmaaldrich. com/catalog/product/aldrich/539007?lang=en®ion=IN [Accessed 21 Jan 2018]. | |
|
USP 40. Dextromethorphan hydrobromide. The United States Pharmacopeial Convention, 2017; 3705-3707. | |
|